Epilepsy in children is a chronic neurological condition characterised by two or more unprovoked, recurring seizures resulting from sudden, abnormal electrical activity in the brain, affecting ...
Parade on MSN
Little girl's 'newborn jitters' were actually recurring seizures, and it happens more often than you think
When "newborn jitters" turned out to be a rare brain condition, Veronica Monclova fought for the surgery that saved her ...
Teacher Yareli Jessica Gijon tells PEOPLE how she manages epilepsy in the classroom and why she posted a seizure video to ...
2UrbanGirls on MSN
Signs that indicate the need for brain tumor surgery — key questions for the neurosurgeon
A brain tumor diagnosis can feel overwhelming. But knowing when surgery is necessary — and how to have the right convers ...
BOSTON and SAN DIEGO, April 21, 2026 (GLOBE NEWSWIRE)-- Rapport Therapeutics, Inc. (Nasdaq: RAPP) ("Rapport” or the "Company”), a clinical-stage biotechnology company dedicated to the discovery and ...
Clinically meaningful efficacy demonstrated in the 8-week follow-up period (weeks 9-16), with a 90% median reduction in clinical seizures over baseline in weeks 9-12 and a 59% median reduction in ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Sleep is not passive rest. It is active repair. During deep sleep, the brain resets electrical activity and balances chemicals that keep signals steady.When sleep falls short, that balance weakens.Dr ...
Xenon Pharmaceuticals’ anti-seizure candidate has smashed a pivotal trial out of the park, lowering seizure rates by more than 50% for some patients as it looks to position itself to become the ...
Azetukalner, a Kv7 potassium channel opener, reduced the frequency of focal onset seizures by a placebo-adjusted rate of 42.7%. Xenon Pharmaceuticals believes this is the highest such efficacy ...
Please provide your email address to receive an email when new articles are posted on . Seizure freedom was observed by 12 months and continued past 48 months of the open-label extension. Long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results